Matrisian, Lynn M.

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research

Global Cancer Incidence and ScreeningColorectal Cancer Screening and Detection

Cited by 7,094

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science

Protease and Inhibitor MechanismsTGF-β signaling in diseases

Cited by 2,761

Estimated Projection of US Cancer Incidence and Death to 2040

Rahib, L., Wehner, M. R., Matrisian, L. M., & Nead, K. T. (2021) · JAMA Network Open

Global Cancer Incidence and ScreeningColorectal Cancer Screening and Detection

Cited by 1,339

Matrix metalloproteinases: they're not just for matrix anymore!

McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology

Protease and Inhibitor MechanismsTGF-β signaling in diseases

Cited by 1,274

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell

Immune cells in cancerAngiogenesis and VEGF in Cancer

Cited by 1,140

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell

TGF-β signaling in diseasesImmune cells in cancer

Cited by 918

Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., & Colburn, N. H. (1994) · Proceedings of the National Academy of Sciences

Protein Kinase Regulation and GTPase SignalingCarcinogens and Genotoxicity Assessment

Cited by 386

Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative

Pishvaian, M. J., Bender, R. J., Halverson, D., Rahib, L., Hendifar, A. E., Mikhail, S., Chung, V., Picozzi, V. J., Sohal, D., Blais, E. M., et al. (2018) · Clinical Cancer Research

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 245

Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review

Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas

AI in cancer detectionPancreatic and Hepatic Oncology Research

Cited by 158

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

Yousef, A., Yousef, M., Chowdhury, S., Abdilleh, K., Knafl, M., Edelkamp, P., Alfaro-Munoz, K., Chacko, R., Peterson, J., Smaglo, B. G., et al. (2024) · npj Precision Oncology

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 93

Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review

Rahib, L., Fleshman, J. M., Matrisian, L. M., & Berlin, J. D. (2016) · JAMA Oncology

Pancreatic and Hepatic Oncology ResearchStatistical Methods in Clinical Trials

Cited by 73

Early detection initiative: a randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma

Chari, S. T., Maitra, A., Matrisian, L. M., Shrader, E. E., Wu, B. U., Kambadakone, A., Zhao, Y.-Q., Kenner, B., Rinaudo, J. A. S., Srivastava, S., et al. (2022) · Contemporary Clinical Trials

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 62

Pancreatic cancer: Patient and caregiver perceptions on diagnosis, psychological impact, and importance of support

Engebretson, A., Matrisian, L., & Thompson, C. (2015) · Pancreatology

Cancer survivorship and carePancreatic and Hepatic Oncology Research

Cited by 49

Potential cost-effectiveness of risk-based pancreatic cancer screening in patients with new-onset diabetes

Schwartz, N. R. M., Matrisian, L. M., Shrader, E. E., Feng, Z., Chari, S., & Roth, J. A. (2022) · Journal of the National Comprehensive Cancer Network

Pancreatic and Hepatic Oncology ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 43

Precision Promise (PrP): an adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC)

Picozzi, V. J., Duliege, A.-M., Collisson, E. A., Maitra, A., Hidalgo, M., Hendifar, A. E., Beatty, G. L., Doss, S., Matrisian, L. M., Herena, P. S., et al. (2022) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchStatistical Methods in Clinical Trials

Cited by 9